Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade
Clinical trial NCT02384317 · COMPLETED
Trial details
- NCT number
- NCT02384317
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-27
- Primary completion
- 2015-09-13
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.